Merit Medical Systems
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is -3.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 6.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 31.6x | Better than 20% |
| Forward P/E | 27.9x | Better than 20% |
| Price / Sales | 3.2x | Better than 39% |
| P/E vs own 5-yr range | 7th pctl | Better than 93% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 9.6% | Better than 63% |
| Net income CAGR (3Y) | 19.9% | Better than 72% |
| Free cash flow CAGR (3Y) | 47.6% | Better than 83% |
Profitability B-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 48.7% | Better than 61% |
| Operating margin | 12.3% | Better than 57% |
| Net margin | 8.5% | Better than 55% |
| Return on equity | 8.7% | Better than 47% |
| Return on invested capital | 6.0% | Better than 50% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -7.1% | Better than 57% |
| 6-month return | 31.4% | Better than 90% |
| 12-month return (ex latest month) | 7.0% | Better than 42% |
| Distance below 52-week high | 11.1% | Better than 81% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.3x | Better than 83% |
| Debt to assets | 30.6% | Better than 40% |
| Interest coverage | 7.5x | Better than 66% |
| Free cash flow / net income | 165.4% | Better than 70% |
Analyst View B+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 31.8% | Better than 51% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 84.41
- Open
- 84.58
- Day range
- 83.89 - 86.20
- Avg price
- 84.43
- Volume
- 560.27K
- Turnover
- 47.31M
- Turnover ratei
- 0.96%
- Volume ratioi
- 1.01
- Amplitudei
- 2.73%
- 52-week rangei
- 59.74 - 94.85
Valuation
- P/Ei
- 39.60
- P/E (TTM)i
- 31.59
- P/Bi
- 2.90
- EPSi
- 2.13
- Book value / shi
- 29.12
- Net profit
- 127.62M
- Net assets
- 1.74B
Share structure
- Market cap
- 5.05B
- Float capi
- 4.93B
- Shares out
- 59.92M
- Float sharesi
- 58.51M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
11.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-2.76M net over the window
Short interest
- Shares short
- 4.00M
- % of floati
- 6.67%
- Days to coveri
- 5.11
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Merit Medical Systems (MMSI)?
Merit Medical Systems last traded at 84.34. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Merit Medical Systems's market cap?
About 5.05B.
What is the P/E ratio of Merit Medical Systems?
The trailing twelve-month P/E is 31.59, below its own 5-year average of 50.80 — toward the bottom of its historical range (6.70% percentile). See the Valuation tab for the full history.
Does Merit Medical Systems pay a dividend?
Merit Medical Systems does not currently pay a regular dividend.
Is Merit Medical Systems a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 111.14, which implies 31.8% upside from the current price. This is not investment advice.
What is Merit Medical Systems's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Merit Medical Systems a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Merit Medical Systems discussion 0 comments